anthraquinone derivative
Recently Published Documents


TOTAL DOCUMENTS

114
(FIVE YEARS 7)

H-INDEX

20
(FIVE YEARS 0)

2021 ◽  
Vol 190 ◽  
pp. 112854
Author(s):  
Ruchi Badoni Semwal ◽  
Deepak Kumar Semwal ◽  
Sandra Combrinck ◽  
Alvaro Viljoen

Small ◽  
2021 ◽  
pp. 2101003
Author(s):  
Yushan Chen ◽  
Zebin Yu ◽  
Ronghua Jiang ◽  
Jun Huang ◽  
Yanping Hou ◽  
...  

2021 ◽  
Vol 124 ◽  
pp. 106962
Author(s):  
Xiaomei Yan ◽  
Charlotte Uldahl Jansen ◽  
Fangyuan Diao ◽  
Katrine Qvortrup ◽  
David Tanner ◽  
...  

2021 ◽  
Author(s):  
Yi Zhu ◽  
Junyi Pi ◽  
Yuchao Zhang ◽  
Dandan Xu ◽  
Yusuf Yagci ◽  
...  

A new UV and visible light photoinitiator, quinizarin derivative 6,11-dimethoxy-7,10-dihydrotetracene-5,12-dione (Q4) was synthesized and characterized. Photophysical properties were evaluated by various spectroscopic and computational investigations. Q4 demonstrates excellent initiating efficiency...


Author(s):  
Rui Pei ◽  
Yueping Jiang ◽  
Guanghua Lei ◽  
Jingjing Chen ◽  
Manhua Liu ◽  
...  

: Rhein, an anthraquinone derivative, has been employed widely, especially for the treatment of intractable diseases like diabetic nephropathy, arthritis, and cancer in a unique action mechanism. In the last decades, considerable efforts have been made in structural modification of rhein. This paper reviewed patents on pharmacological activity and therapeutic application of rhein and its derivatives from 1978 to 2018. Particularly, an analysis of patents was made, with the top 10 most valuable patents presented, and the interpretation of the legal status of patents was given. Given the properties of superior pharmacological activity, rich resources, cheap price, low toxicity, and mature extraction process, it is believed that an in-depth investigation on rhein and its derivatives is worth trying.


Sign in / Sign up

Export Citation Format

Share Document